Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma

Abstract Background Neuroendocrine prostate cancer (NEPC) may be rising in prevalence as patients with advanced prostate cancer potentially develop resistance to contemporary anti-androgen treatment through a neuroendocrine phenotype. While prior studies comparing NEPC and prostatic adenocarcinoma h...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Harrison K. Tsai, Jonathan Lehrer, Mohammed Alshalalfa, Nicholas Erho, Elai Davicioni, Tamara L. Lotan
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMC 2017-11-01
Serie:BMC Cancer
Soggetti:
Neuroendocrine prostate cancer
Small cell carcinoma
Mixed prostatic adenocarcinoma
FFPE
Gene signature
Meta-analysis
Accesso online:http://link.springer.com/article/10.1186/s12885-017-3729-z
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi